Please login to access the CRTOnline.
Judge blocks Edwards’ JenaValve acquisition—FTC calls it a ‘major win’ for Trump administration
The U.S. Federal Trade Commission (FTC) has successfully stopped Edwards Lifesciences from following through with its $945 million acquisition of JenaValve.